Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Size Growth Rate by Type, 2018 VS 2022 VS 2033
1.2.2 Abecma
1.2.3 Breyanzi
1.2.4 Kymriah
1.2.5 Tecartus
1.2.6 Yescarta
1.2.7 Others
1.3 Market by Application
1.3.1 Global Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Size Growth Rate by Application, 2018 VS 2022 VS 2033
1.3.2 Hospital
1.3.3 Diagnostic Center
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Perspective (2018-2033)
2.2 Global Chimeric Antigen Receptor (CAR)-T Cell Therapy Growth Trends by Region
2.2.1 Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Chimeric Antigen Receptor (CAR)-T Cell Therapy Historic Market Size by Region (2018-2023)
2.2.3 Chimeric Antigen Receptor (CAR)-T Cell Therapy Forecasted Market Size by Region (2024-2033)
2.3 Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Dynamics
2.3.1 Chimeric Antigen Receptor (CAR)-T Cell Therapy Industry Trends
2.3.2 Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Drivers
2.3.3 Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Challenges
2.3.4 Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Chimeric Antigen Receptor (CAR)-T Cell Therapy by Players
3.1.1 Global Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue by Players (2018-2023)
3.1.2 Global Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue Market Share by Players (2018-2023)
3.2 Global Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Chimeric Antigen Receptor (CAR)-T Cell Therapy, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Concentration Ratio
3.4.1 Global Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue in 2022
3.5 Global Key Players of Chimeric Antigen Receptor (CAR)-T Cell Therapy Head office and Area Served
3.6 Global Key Players of Chimeric Antigen Receptor (CAR)-T Cell Therapy, Product and Application
3.7 Global Key Players of Chimeric Antigen Receptor (CAR)-T Cell Therapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Chimeric Antigen Receptor (CAR)-T Cell Therapy Breakdown Data by Type
4.1 Global Chimeric Antigen Receptor (CAR)-T Cell Therapy Historic Market Size by Type (2018-2023)
4.2 Global Chimeric Antigen Receptor (CAR)-T Cell Therapy Forecasted Market Size by Type (2024-2033)
5 Chimeric Antigen Receptor (CAR)-T Cell Therapy Breakdown Data by Application
5.1 Global Chimeric Antigen Receptor (CAR)-T Cell Therapy Historic Market Size by Application (2018-2023)
5.2 Global Chimeric Antigen Receptor (CAR)-T Cell Therapy Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Size (2018-2033)
6.2 North America Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Size by Type
6.2.1 North America Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Size by Type (2018-2023)
6.2.2 North America Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Size by Type (2024-2033)
6.2.3 North America Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Share by Type (2018-2033)
6.3 North America Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Size by Application
6.3.1 North America Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Size by Application (2018-2023)
6.3.2 North America Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Size by Application (2024-2033)
6.3.3 North America Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Share by Application (2018-2033)
6.4 North America Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Size by Country
6.4.1 North America Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Size by Country: 2018 VS 2022 VS 2033
6.4.2 North America Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Size by Country (2018-2023)
6.4.3 North America Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Size by Country (2024-2033)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Size (2018-2033)
7.2 Europe Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Size by Type
7.2.1 Europe Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Size by Type (2018-2023)
7.2.2 Europe Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Size by Type (2024-2033)
7.2.3 Europe Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Share by Type (2018-2033)
7.3 Europe Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Size by Application
7.3.1 Europe Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Size by Application (2018-2023)
7.3.2 Europe Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Size by Application (2024-2033)
7.3.3 Europe Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Share by Application (2018-2033)
7.4 Europe Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Size by Country
7.4.1 Europe Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Size by Country: 2018 VS 2022 VS 2033
7.4.2 Europe Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Size by Country (2018-2023)
7.4.3 Europe Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Size by Country (2024-2033)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Size (2018-2033)
8.2 China Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Size by Type
8.2.1 China Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Size by Type (2018-2023)
8.2.2 China Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Size by Type (2024-2033)
8.2.3 China Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Share by Type (2018-2033)
8.3 China Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Size by Application
8.3.1 China Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Size by Application (2018-2023)
8.3.2 China Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Size by Application (2024-2033)
8.3.3 China Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Share by Application (2018-2033)
9 Asia (excluding China)
9.1 Asia Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Size (2018-2033)
9.2 Asia Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Size by Type
9.2.1 Asia Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Size by Type (2018-2023)
9.2.2 Asia Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Size by Type (2024-2033)
9.2.3 Asia Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Share by Type (2018-2033)
9.3 Asia Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Size by Application
9.3.1 Asia Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Size by Application (2018-2023)
9.3.2 Asia Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Size by Application (2024-2033)
9.3.3 Asia Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Share by Application (2018-2033)
9.4 Asia Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Size by Region
9.4.1 Asia Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Size by Region: 2018 VS 2022 VS 2033
9.4.2 Asia Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Size by Region (2018-2023)
9.4.3 Asia Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Size by Region (2024-2033)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Size (2018-2033)
10.2 Middle East, Africa, and Latin America Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Size by Type
10.2.1 Middle East, Africa, and Latin America Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Size by Type (2024-2033)
10.2.3 Middle East, Africa, and Latin America Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Share by Type (2018-2033)
10.3 Middle East, Africa, and Latin America Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Size by Application
10.3.1 Middle East, Africa, and Latin America Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Size by Application (2024-2033)
10.3.3 Middle East, Africa, and Latin America Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Share by Application (2018-2033)
10.4 Middle East, Africa, and Latin America Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Size by Country
10.4.1 Middle East, Africa, and Latin America Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Size by Country: 2018 VS 2022 VS 2033
10.4.2 Middle East, Africa, and Latin America Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Size by Country (2024-2033)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Autolus Therapeutics
11.1.1 Autolus Therapeutics Company Details
11.1.2 Autolus Therapeutics Business Overview
11.1.3 Autolus Therapeutics Chimeric Antigen Receptor (CAR)-T Cell Therapy Introduction
11.1.4 Autolus Therapeutics Revenue in Chimeric Antigen Receptor (CAR)-T Cell Therapy Business (2018-2023)
11.1.5 Autolus Therapeutics Recent Developments
11.2 CARsgen Therapeutics
11.2.1 CARsgen Therapeutics Company Details
11.2.2 CARsgen Therapeutics Business Overview
11.2.3 CARsgen Therapeutics Chimeric Antigen Receptor (CAR)-T Cell Therapy Introduction
11.2.4 CARsgen Therapeutics Revenue in Chimeric Antigen Receptor (CAR)-T Cell Therapy Business (2018-2023)
11.2.5 CARsgen Therapeutics Recent Developments
11.3 Juno Therapeutics
11.3.1 Juno Therapeutics Company Details
11.3.2 Juno Therapeutics Business Overview
11.3.3 Juno Therapeutics Chimeric Antigen Receptor (CAR)-T Cell Therapy Introduction
11.3.4 Juno Therapeutics Revenue in Chimeric Antigen Receptor (CAR)-T Cell Therapy Business (2018-2023)
11.3.5 Juno Therapeutics Recent Developments
11.4 Sorrento Therapeutics
11.4.1 Sorrento Therapeutics Company Details
11.4.2 Sorrento Therapeutics Business Overview
11.4.3 Sorrento Therapeutics Chimeric Antigen Receptor (CAR)-T Cell Therapy Introduction
11.4.4 Sorrento Therapeutics Revenue in Chimeric Antigen Receptor (CAR)-T Cell Therapy Business (2018-2023)
11.4.5 Sorrento Therapeutics Recent Developments
11.5 bluebird bio
11.5.1 bluebird bio Company Details
11.5.2 bluebird bio Business Overview
11.5.3 bluebird bio Chimeric Antigen Receptor (CAR)-T Cell Therapy Introduction
11.5.4 bluebird bio Revenue in Chimeric Antigen Receptor (CAR)-T Cell Therapy Business (2018-2023)
11.5.5 bluebird bio Recent Developments
11.6 CELGENE CORPORATION
11.6.1 CELGENE CORPORATION Company Details
11.6.2 CELGENE CORPORATION Business Overview
11.6.3 CELGENE CORPORATION Chimeric Antigen Receptor (CAR)-T Cell Therapy Introduction
11.6.4 CELGENE CORPORATION Revenue in Chimeric Antigen Receptor (CAR)-T Cell Therapy Business (2018-2023)
11.6.5 CELGENE CORPORATION Recent Developments
11.7 Eureka Therapeutics
11.7.1 Eureka Therapeutics Company Details
11.7.2 Eureka Therapeutics Business Overview
11.7.3 Eureka Therapeutics Chimeric Antigen Receptor (CAR)-T Cell Therapy Introduction
11.7.4 Eureka Therapeutics Revenue in Chimeric Antigen Receptor (CAR)-T Cell Therapy Business (2018-2023)
11.7.5 Eureka Therapeutics Recent Developments
11.8 Avacta Life Sciences
11.8.1 Avacta Life Sciences Company Details
11.8.2 Avacta Life Sciences Business Overview
11.8.3 Avacta Life Sciences Chimeric Antigen Receptor (CAR)-T Cell Therapy Introduction
11.8.4 Avacta Life Sciences Revenue in Chimeric Antigen Receptor (CAR)-T Cell Therapy Business (2018-2023)
11.8.5 Avacta Life Sciences Recent Developments
11.9 Calyxt
11.9.1 Calyxt Company Details
11.9.2 Calyxt Business Overview
11.9.3 Calyxt Chimeric Antigen Receptor (CAR)-T Cell Therapy Introduction
11.9.4 Calyxt Revenue in Chimeric Antigen Receptor (CAR)-T Cell Therapy Business (2018-2023)
11.9.5 Calyxt Recent Developments
11.10 Celyad Oncology SA
11.10.1 Celyad Oncology SA Company Details
11.10.2 Celyad Oncology SA Business Overview
11.10.3 Celyad Oncology SA Chimeric Antigen Receptor (CAR)-T Cell Therapy Introduction
11.10.4 Celyad Oncology SA Revenue in Chimeric Antigen Receptor (CAR)-T Cell Therapy Business (2018-2023)
11.10.5 Celyad Oncology SA Recent Developments
11.11 Fortress Biotech
11.11.1 Fortress Biotech Company Details
11.11.2 Fortress Biotech Business Overview
11.11.3 Fortress Biotech Chimeric Antigen Receptor (CAR)-T Cell Therapy Introduction
11.11.4 Fortress Biotech Revenue in Chimeric Antigen Receptor (CAR)-T Cell Therapy Business (2018-2023)
11.11.5 Fortress Biotech Recent Developments
11.12 IMMUNE THERAPEUTICS
11.12.1 IMMUNE THERAPEUTICS Company Details
11.12.2 IMMUNE THERAPEUTICS Business Overview
11.12.3 IMMUNE THERAPEUTICS Chimeric Antigen Receptor (CAR)-T Cell Therapy Introduction
11.12.4 IMMUNE THERAPEUTICS Revenue in Chimeric Antigen Receptor (CAR)-T Cell Therapy Business (2018-2023)
11.12.5 IMMUNE THERAPEUTICS Recent Developments
11.13 Gilead Sciences
11.13.1 Gilead Sciences Company Details
11.13.2 Gilead Sciences Business Overview
11.13.3 Gilead Sciences Chimeric Antigen Receptor (CAR)-T Cell Therapy Introduction
11.13.4 Gilead Sciences Revenue in Chimeric Antigen Receptor (CAR)-T Cell Therapy Business (2018-2023)
11.13.5 Gilead Sciences Recent Developments
11.14 Novartis AG
11.14.1 Novartis AG Company Details
11.14.2 Novartis AG Business Overview
11.14.3 Novartis AG Chimeric Antigen Receptor (CAR)-T Cell Therapy Introduction
11.14.4 Novartis AG Revenue in Chimeric Antigen Receptor (CAR)-T Cell Therapy Business (2018-2023)
11.14.5 Novartis AG Recent Developments
11.15 Alaunos Therapeutics
11.15.1 Alaunos Therapeutics Company Details
11.15.2 Alaunos Therapeutics Business Overview
11.15.3 Alaunos Therapeutics Chimeric Antigen Receptor (CAR)-T Cell Therapy Introduction
11.15.4 Alaunos Therapeutics Revenue in Chimeric Antigen Receptor (CAR)-T Cell Therapy Business (2018-2023)
11.15.5 Alaunos Therapeutics Recent Developments
11.16 Poseida Therapeutics
11.16.1 Poseida Therapeutics Company Details
11.16.2 Poseida Therapeutics Business Overview
11.16.3 Poseida Therapeutics Chimeric Antigen Receptor (CAR)-T Cell Therapy Introduction
11.16.4 Poseida Therapeutics Revenue in Chimeric Antigen Receptor (CAR)-T Cell Therapy Business (2018-2023)
11.16.5 Poseida Therapeutics Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2033
Table 2. Key Players of Abecma
Table 3. Key Players of Breyanzi
Table 4. Key Players of Kymriah
Table 5. Key Players of Tecartus
Table 6. Key Players of Yescarta
Table 7. Key Players of Others
Table 8. Global Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2033
Table 9. Global Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 10. Global Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Size by Region (2018-2023) & (US$ Million)
Table 11. Global Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Share by Region (2018-2023)
Table 12. Global Chimeric Antigen Receptor (CAR)-T Cell Therapy Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 13. Global Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Share by Region (2024-2033)
Table 14. Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Trends
Table 15. Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Drivers
Table 16. Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Challenges
Table 17. Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Restraints
Table 18. Global Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue by Players (2018-2023) & (US$ Million)
Table 19. Global Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue Share by Players (2018-2023)
Table 20. Global Top Chimeric Antigen Receptor (CAR)-T Cell Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chimeric Antigen Receptor (CAR)-T Cell Therapy as of 2022)
Table 21. Global Chimeric Antigen Receptor (CAR)-T Cell Therapy Industry Ranking 2021 VS 2022 VS 2023
Table 22. Global 5 Largest Players Market Share by Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue (CR5 and HHI) & (2018-2023)
Table 23. Global Key Players of Chimeric Antigen Receptor (CAR)-T Cell Therapy, Headquarters and Area Served
Table 24. Global Key Players of Chimeric Antigen Receptor (CAR)-T Cell Therapy, Product and Application
Table 25. Global Key Players of Chimeric Antigen Receptor (CAR)-T Cell Therapy, Product and Application
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 28. Global Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue Market Share by Type (2018-2023)
Table 29. Global Chimeric Antigen Receptor (CAR)-T Cell Therapy Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 30. Global Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue Market Share by Type (2024-2033)
Table 31. Global Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 32. Global Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue Share by Application (2018-2023)
Table 33. Global Chimeric Antigen Receptor (CAR)-T Cell Therapy Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 34. Global Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue Share by Application (2024-2033)
Table 35. North America Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 36. North America Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Size by Type (2024-2033) & (US$ Million)
Table 37. North America Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 38. North America Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Size by Application (2024-2033) & (US$ Million)
Table 39. North America Chimeric Antigen Receptor (CAR)-T Cell Therapy Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 40. North America Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 41. North America Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Size by Country (2024-2033) & (US$ Million)
Table 42. Europe Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 43. Europe Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Size by Type (2024-2033) & (US$ Million)
Table 44. Europe Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 45. Europe Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Size by Application (2024-2033) & (US$ Million)
Table 46. Europe Chimeric Antigen Receptor (CAR)-T Cell Therapy Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 47. Europe Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 48. Europe Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Size by Country (2024-2033) & (US$ Million)
Table 49. China Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 50. China Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Size by Type (2024-2033) & (US$ Million)
Table 51. China Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 52. China Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Size by Application (2024-2033) & (US$ Million)
Table 53. Asia Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 54. Asia Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Size by Type (2024-2033) & (US$ Million)
Table 55. Asia Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 56. Asia Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Size by Application (2024-2033) & (US$ Million)
Table 57. Asia Chimeric Antigen Receptor (CAR)-T Cell Therapy Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 58. Asia Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Size by Region (2018-2023) & (US$ Million)
Table 59. Asia Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Size by Region (2024-2033) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Size by Type (2024-2033) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Size by Application (2024-2033) & (US$ Million)
Table 64. Middle East, Africa, and Latin America Chimeric Antigen Receptor (CAR)-T Cell Therapy Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 65. Middle East, Africa, and Latin America Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 66. Middle East, Africa, and Latin America Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Size by Country (2024-2033) & (US$ Million)
Table 67. Autolus Therapeutics Company Details
Table 68. Autolus Therapeutics Business Overview
Table 69. Autolus Therapeutics Chimeric Antigen Receptor (CAR)-T Cell Therapy Product
Table 70. Autolus Therapeutics Revenue in Chimeric Antigen Receptor (CAR)-T Cell Therapy Business (2018-2023) & (US$ Million)
Table 71. Autolus Therapeutics Recent Developments
Table 72. CARsgen Therapeutics Company Details
Table 73. CARsgen Therapeutics Business Overview
Table 74. CARsgen Therapeutics Chimeric Antigen Receptor (CAR)-T Cell Therapy Product
Table 75. CARsgen Therapeutics Revenue in Chimeric Antigen Receptor (CAR)-T Cell Therapy Business (2018-2023) & (US$ Million)
Table 76. CARsgen Therapeutics Recent Developments
Table 77. Juno Therapeutics Company Details
Table 78. Juno Therapeutics Business Overview
Table 79. Juno Therapeutics Chimeric Antigen Receptor (CAR)-T Cell Therapy Product
Table 80. Juno Therapeutics Revenue in Chimeric Antigen Receptor (CAR)-T Cell Therapy Business (2018-2023) & (US$ Million)
Table 81. Juno Therapeutics Recent Developments
Table 82. Sorrento Therapeutics Company Details
Table 83. Sorrento Therapeutics Business Overview
Table 84. Sorrento Therapeutics Chimeric Antigen Receptor (CAR)-T Cell Therapy Product
Table 85. Sorrento Therapeutics Revenue in Chimeric Antigen Receptor (CAR)-T Cell Therapy Business (2018-2023) & (US$ Million)
Table 86. Sorrento Therapeutics Recent Developments
Table 87. bluebird bio Company Details
Table 88. bluebird bio Business Overview
Table 89. bluebird bio Chimeric Antigen Receptor (CAR)-T Cell Therapy Product
Table 90. bluebird bio Revenue in Chimeric Antigen Receptor (CAR)-T Cell Therapy Business (2018-2023) & (US$ Million)
Table 91. bluebird bio Recent Developments
Table 92. CELGENE CORPORATION Company Details
Table 93. CELGENE CORPORATION Business Overview
Table 94. CELGENE CORPORATION Chimeric Antigen Receptor (CAR)-T Cell Therapy Product
Table 95. CELGENE CORPORATION Revenue in Chimeric Antigen Receptor (CAR)-T Cell Therapy Business (2018-2023) & (US$ Million)
Table 96. CELGENE CORPORATION Recent Developments
Table 97. Eureka Therapeutics Company Details
Table 98. Eureka Therapeutics Business Overview
Table 99. Eureka Therapeutics Chimeric Antigen Receptor (CAR)-T Cell Therapy Product
Table 100. Eureka Therapeutics Revenue in Chimeric Antigen Receptor (CAR)-T Cell Therapy Business (2018-2023) & (US$ Million)
Table 101. Eureka Therapeutics Recent Developments
Table 102. Avacta Life Sciences Company Details
Table 103. Avacta Life Sciences Business Overview
Table 104. Avacta Life Sciences Chimeric Antigen Receptor (CAR)-T Cell Therapy Product
Table 105. Avacta Life Sciences Revenue in Chimeric Antigen Receptor (CAR)-T Cell Therapy Business (2018-2023) & (US$ Million)
Table 106. Avacta Life Sciences Recent Developments
Table 107. Calyxt Company Details
Table 108. Calyxt Business Overview
Table 109. Calyxt Chimeric Antigen Receptor (CAR)-T Cell Therapy Product
Table 110. Calyxt Revenue in Chimeric Antigen Receptor (CAR)-T Cell Therapy Business (2018-2023) & (US$ Million)
Table 111. Calyxt Recent Developments
Table 112. Celyad Oncology SA Company Details
Table 113. Celyad Oncology SA Business Overview
Table 114. Celyad Oncology SA Chimeric Antigen Receptor (CAR)-T Cell Therapy Product
Table 115. Celyad Oncology SA Revenue in Chimeric Antigen Receptor (CAR)-T Cell Therapy Business (2018-2023) & (US$ Million)
Table 116. Celyad Oncology SA Recent Developments
Table 117. Fortress Biotech Company Details
Table 118. Fortress Biotech Business Overview
Table 119. Fortress Biotech Chimeric Antigen Receptor (CAR)-T Cell Therapy Product
Table 120. Fortress Biotech Revenue in Chimeric Antigen Receptor (CAR)-T Cell Therapy Business (2018-2023) & (US$ Million)
Table 121. Fortress Biotech Recent Developments
Table 122. IMMUNE THERAPEUTICS Company Details
Table 123. IMMUNE THERAPEUTICS Business Overview
Table 124. IMMUNE THERAPEUTICS Chimeric Antigen Receptor (CAR)-T Cell Therapy Product
Table 125. IMMUNE THERAPEUTICS Revenue in Chimeric Antigen Receptor (CAR)-T Cell Therapy Business (2018-2023) & (US$ Million)
Table 126. IMMUNE THERAPEUTICS Recent Developments
Table 127. Gilead Sciences Company Details
Table 128. Gilead Sciences Business Overview
Table 129. Gilead Sciences Chimeric Antigen Receptor (CAR)-T Cell Therapy Product
Table 130. Gilead Sciences Revenue in Chimeric Antigen Receptor (CAR)-T Cell Therapy Business (2018-2023) & (US$ Million)
Table 131. Gilead Sciences Recent Developments
Table 132. Novartis AG Company Details
Table 133. Novartis AG Business Overview
Table 134. Novartis AG Chimeric Antigen Receptor (CAR)-T Cell Therapy Product
Table 135. Novartis AG Revenue in Chimeric Antigen Receptor (CAR)-T Cell Therapy Business (2018-2023) & (US$ Million)
Table 136. Novartis AG Recent Developments
Table 137. Alaunos Therapeutics Company Details
Table 138. Alaunos Therapeutics Business Overview
Table 139. Alaunos Therapeutics Chimeric Antigen Receptor (CAR)-T Cell Therapy Product
Table 140. Alaunos Therapeutics Revenue in Chimeric Antigen Receptor (CAR)-T Cell Therapy Business (2018-2023) & (US$ Million)
Table 141. Alaunos Therapeutics Recent Developments
Table 142. Poseida Therapeutics Company Details
Table 143. Poseida Therapeutics Business Overview
Table 144. Poseida Therapeutics Chimeric Antigen Receptor (CAR)-T Cell Therapy Product
Table 145. Poseida Therapeutics Revenue in Chimeric Antigen Receptor (CAR)-T Cell Therapy Business (2018-2023) & (US$ Million)
Table 146. Poseida Therapeutics Recent Developments
Table 147. Research Programs/Design for This Report
Table 148. Key Data Information from Secondary Sources
Table 149. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Size Growth Rate by Type, 2018 VS 2022 VS 2033 (US$ Million)
Figure 2. Global Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Share by Type: 2022 VS 2033
Figure 3. Abecma Features
Figure 4. Breyanzi Features
Figure 5. Kymriah Features
Figure 6. Tecartus Features
Figure 7. Yescarta Features
Figure 8. Others Features
Figure 9. Global Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Size Growth Rate by Application, 2018 VS 2022 VS 2033 (US$ Million)
Figure 10. Global Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Share by Application: 2022 VS 2033
Figure 11. Hospital Case Studies
Figure 12. Diagnostic Center Case Studies
Figure 13. Other Case Studies
Figure 14. Chimeric Antigen Receptor (CAR)-T Cell Therapy Report Years Considered
Figure 15. Global Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 16. Global Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 17. Global Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Share by Region: 2022 VS 2033
Figure 18. Global Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Share by Players in 2022
Figure 19. Global Top Chimeric Antigen Receptor (CAR)-T Cell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chimeric Antigen Receptor (CAR)-T Cell Therapy as of 2022)
Figure 20. The Top 10 and 5 Players Market Share by Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue in 2022
Figure 21. North America Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. North America Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Share by Type (2018-2033)
Figure 23. North America Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Share by Application (2018-2033)
Figure 24. North America Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Share by Country (2018-2033)
Figure 25. United States Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Canada Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Europe Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Size YoY (2018-2033) & (US$ Million)
Figure 28. Europe Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Share by Type (2018-2033)
Figure 29. Europe Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Share by Application (2018-2033)
Figure 30. Europe Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Share by Country (2018-2033)
Figure 31. Germany Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. France Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. U.K. Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Italy Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Russia Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Nordic Countries Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. China Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Size YoY (2018-2033) & (US$ Million)
Figure 38. China Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Share by Type (2018-2033)
Figure 39. China Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Share by Application (2018-2033)
Figure 40. Asia Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Size YoY (2018-2033) & (US$ Million)
Figure 41. Asia Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Share by Type (2018-2033)
Figure 42. Asia Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Share by Application (2018-2033)
Figure 43. Asia Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Share by Region (2018-2033)
Figure 44. Japan Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. South Korea Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. China Taiwan Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Southeast Asia Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. India Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 49. Australia Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 50. Middle East, Africa, and Latin America Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Size YoY (2018-2033) & (US$ Million)
Figure 51. Middle East, Africa, and Latin America Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Share by Type (2018-2033)
Figure 52. Middle East, Africa, and Latin America Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Share by Application (2018-2033)
Figure 53. Middle East, Africa, and Latin America Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Share by Country (2018-2033)
Figure 54. Brazil Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 55. Mexico Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 56. Turkey Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 57. Saudi Arabia Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 58. Israel Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 59. GCC Countries Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 60. Autolus Therapeutics Revenue Growth Rate in Chimeric Antigen Receptor (CAR)-T Cell Therapy Business (2018-2023)
Figure 61. CARsgen Therapeutics Revenue Growth Rate in Chimeric Antigen Receptor (CAR)-T Cell Therapy Business (2018-2023)
Figure 62. Juno Therapeutics Revenue Growth Rate in Chimeric Antigen Receptor (CAR)-T Cell Therapy Business (2018-2023)
Figure 63. Sorrento Therapeutics Revenue Growth Rate in Chimeric Antigen Receptor (CAR)-T Cell Therapy Business (2018-2023)
Figure 64. bluebird bio Revenue Growth Rate in Chimeric Antigen Receptor (CAR)-T Cell Therapy Business (2018-2023)
Figure 65. CELGENE CORPORATION Revenue Growth Rate in Chimeric Antigen Receptor (CAR)-T Cell Therapy Business (2018-2023)
Figure 66. Eureka Therapeutics Revenue Growth Rate in Chimeric Antigen Receptor (CAR)-T Cell Therapy Business (2018-2023)
Figure 67. Avacta Life Sciences Revenue Growth Rate in Chimeric Antigen Receptor (CAR)-T Cell Therapy Business (2018-2023)
Figure 68. Calyxt Revenue Growth Rate in Chimeric Antigen Receptor (CAR)-T Cell Therapy Business (2018-2023)
Figure 69. Celyad Oncology SA Revenue Growth Rate in Chimeric Antigen Receptor (CAR)-T Cell Therapy Business (2018-2023)
Figure 70. Fortress Biotech Revenue Growth Rate in Chimeric Antigen Receptor (CAR)-T Cell Therapy Business (2018-2023)
Figure 71. IMMUNE THERAPEUTICS Revenue Growth Rate in Chimeric Antigen Receptor (CAR)-T Cell Therapy Business (2018-2023)
Figure 72. Gilead Sciences Revenue Growth Rate in Chimeric Antigen Receptor (CAR)-T Cell Therapy Business (2018-2023)
Figure 73. Novartis AG Revenue Growth Rate in Chimeric Antigen Receptor (CAR)-T Cell Therapy Business (2018-2023)
Figure 74. Alaunos Therapeutics Revenue Growth Rate in Chimeric Antigen Receptor (CAR)-T Cell Therapy Business (2018-2023)
Figure 75. Poseida Therapeutics Revenue Growth Rate in Chimeric Antigen Receptor (CAR)-T Cell Therapy Business (2018-2023)
Figure 76. Bottom-up and Top-down Approaches for This Report
Figure 77. Data Triangulation
Figure 78. Key Executives Interviewed